Abstract

BackgroundPreventing organ damage is a major challenge in management of Systemic Lupus Erythematosus (SLE). Few data are available on factors related to development of damage in early stages of the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AB1125 Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models
G Galvan ... M Sciandrone
Annals of the Rheumatic Diseases | VOL. 76
G Galvan, et. al.G Galvan ... M Sciandrone
01 Jun 2017
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
...
Annals of the Rheumatic Diseases | VOL. 74
, et. al. ...
16 May 2014
FRI0376 Dyslipidemia as a newly recognisedfactor associated with damage accrual in early diagnosed sle: results from the multicenter early lupus project inception cohort
...
Annals of the Rheumatic Diseases | VOL. 77
, et. al. ...
01 Jun 2018
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models.
Fabrizio Conti ... Carlo Perricone
PloS one | VOL. 12
Fabrizio Conti, et. al.Fabrizio Conti ... Carlo Perricone
22 Mar 2017
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers